- STAT+: Fatal gene-editing trial in China raises ethics and oversight questionsSanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The ReadoutSTAT · 1h ago↗ source
- STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and moreIn a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugsSTAT · 1h ago↗ source
- CHMP recommends Minoryx’s ALD drug, rejects Zevra’s MeplyffaMinoryx Therapeutics finally scored backing from EU regulators for its neurological drug that’s faced multiple hurdles. Meanwhile, Zevra’s rare disease drug got a setback in Europe almost two years…